Avastin Hearing: The Interrogators
You may also be interested in...
Breakthrough Therapies: Maintain The Statistical Rigor, Industry Says
Janssen statistician says FDA should ensure breakthrough sponsors follow the rules just like traditional applicants, although agency statistician experience with designees has been limited.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”